Pramipexole in Parkinson’s disease

Shindriaeva N.N.; Gan'kina O.A.; Levin O.S.

doi:https://doi.org/10.17116/jnevro20151156265-72

Shindriaeva N.N.

Gan'kina O.A.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia, Moskva

Levin O.S.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia

SPIN RSCI: 5342-1373
Scopus AuthorID: 57147160800
ORCID: 0000-0003-3872-5923

Pramipexole in Parkinson’s disease

Authors:

Shindriaeva N.N., Gan'kina O.A., Levin O.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(6‑2): 65‑72

DOI: 10.17116/jnevro20151156265-72

Read: 4086 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Shindriaeva NN, Gan'kina OA, Levin OS. Pramipexole in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(6‑2):65‑72. (In Russ.)
https://doi.org/10.17116/jnevro20151156265-72

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Unresolved problem: Chemotherapy-Induced Peripheral Neuropathy. P.A. Herzen Journal of Oncology. 2024;(5):76-81

Quality assessment of health care delivery to patients with sexually transmitted infections in dermatovenereological institutions of Moscow according to medical records analysis. Russian Journal of Clinical Dermatology and Venereology. 2024;(5):503-509

Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Venereology. 2024;(5):517-524

Tuberculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66

Diagnosis and treatment approaches for sialorrhea in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):29-34

Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72

Clinical presentation and diagnosis of Parkinson’s disease in patients with schizophrenia spectrum disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):73-80

Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90

Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99

Chronic epidural spinal cord stimulation for gait impairments in Parkinson’s disease and atypical parkinsonism. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):100-112

Abstract:

Pramipexole is non-ergoline dopamine receptor agonist. There is accumulating evidence for the efficacy of pramipexole in treatment of Parkinson’s disease (PD). Authors have summarized the results concerning the optimal start treatment, the using of pramipexole in early and advanced PD stages, effects of pramipexole on tremor, cognitive impairment, affective functions and safety pramipexole.

Keywords:

Parkinson’s disease

treatment

pramipexole